[Effect of calciparine in the mid-term treatment of peripheral arteriopathy of the lower extremities].
The authors examine a series of 20 patients suffering from AOCP (?) at Fontaine's 2nd stage treated with calciparine s.c. in a single daily dose of 12500 IU for three months. The parameters of clinical assessment of claudicatio intermittens show statistically significant increases of ILR and ILA which were not correlated to marked variations of the Windsor index. The extremely positive results in terms of the clinical trend of the disease are encouraging with a view to a more extensive application of this therapeutic approach in peripheral arterial disease of the lower limbs.
Stanzani
M
M
Day-Hospital, Ospedale S. Paolo, Milano.
Colombo
L
L
Altomare
S
S
Pagnozzi
G
G
Barbieri
C
C
Bruschi
R
R
Pietrasanta
E
E
D000368:Aged; D004341:Drug Evaluation; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007383:Intermittent Claudication / Q000188:drug therapy*; D007866:Leg / Q000098:blood supply*; D008297:Male; D008875:Middle Aged; D016491:Peripheral Vascular Diseases / Q000188:drug therapy*; D013997:Time Factors
D005343:Fibrinolytic Agents; C006871:calcium heparin; D006493:Heparin
Effetto della calciparina nel trattamento a medio termine dell'arteriopatia periferica degli arti inferiori.